Community-acquired pneumonia (CAP) is the leading cause of death among infectious
diseases and an important health problem, having considerable implications for healthcare …

Introduction: Lower respiratory tract infections (LRTIs) are the leading infectious disease
cause of death in the world and the fifth overall cause of death. From an epidemiological …

Background Despite use of the 13-valent pneumococcal conjugate vaccine (PCV13) and 23-
valent pneumococcal polysaccharide vaccine (PPSV23) over the last decade, the disease …

Following the introduction of pneumococcal conjugate vaccines (PCVs), the rate of invasive
pneumococcal disease (IPD) declined, however, IPDs replaced by serotypes that are not …

Background In Canada, 13-valent pneumococcal conjugate vaccine (PCV13) is
recommended in childhood, in individuals at high risk of invasive pneumococcal disease …

Background Invasive pneumococcal disease (IPD) in people≥ 60 years old is on the rise in
Germany. There has been a recommendation for pneumococcal vaccination in this age …

Despite the availability of a pneumococcal National Immunization Program, which provides
free PPSV23 vaccination for older adults aged≥ 65 years in South Korea, pneumococcal …

Introduction Pneumococcal diseases are common and cause significant morbidity and
mortality, with higher rates especially in developing areas including many in the Asia-Pacific …

Objective To investigate the proportion of aspiration pneumonia cases among patients with
community-acquired pneumonia in Korea. Methods This retrospective study included …

Pneumonia is the leading cause of morbidity and mortality, particularly in old adults. The
incidence and etiologic distribution of community-acquired pneumonia is variable both …